Latest news

8 months 1 week ago
A motion calling on London Mayor Sadiq Khan to take the lead on raising awareness of hepatitis C passed unanimously yesterday in the London Assembly. Susan Hall AM introduced the motion, telling assembly members that hepatitis C is something “we all need to be talking about”. She emphasised that hepatitis C is a “major public health issue”, affecting an estimated 40,000 people living in London and said that Assembly Members “must do all we can” to raise awareness about new, effective treatments to “eradicate this in London”.
8 months 2 weeks ago
New research published today in The Lancet models the impact of public health interventions on the global hepatitis epidemic to investigate whether elimination targets set by the World Health Organization (WHO) can be met. If improvements are made, the target to reduce the number of new hepatitis C infections by 80% could be met in 2030 and the target to reduce mortality by 65% could be met in 2032, according to the study.
8 months 3 weeks ago
The Infected Blood Inquiry has confirmed the dates and venues for the first public hearings when people infected and affected will give oral evidence. The dates and locations are as follows: London (Fleetbank House) - 30 April-3 May, 7-10 May Belfast (International Conference Centre Belfast) - 21-24 May
8 months 3 weeks ago
Evidence from a new study shows that needle and syringe programmes providing clean injecting equipment are a highly cost-effective way of preventing hepatitis C transmission. New research led by the University of Bristol and London School of Hygiene and Topical Medicine reveals that rolling out these programmes could save millions of pounds in infection treatment costs in the UK. This is the first study to evaluate the cost-effectiveness of needle and syringe programmes in Western Europe.
9 months 1 week ago
The Infected Blood Inquiry has appointed three trained professionals to assist in collecting evidence and producing narrative summaries. The announcement comes after many people told the Inquiry that stigma attached to their experiences makes providing witness statements or oral testimony difficult.
9 months 2 weeks ago
The Public Health England (PHE) Hepatitis C Virus Resistance Group last month released a report, 'Antiviral resistance testing in the management of hepatitis C virus infection', to support clinicians treating people with hepatitis C where the issue of resistance may be a factor in clinical decision-making.  The report makes a series of recommendations related to resistance-associated substitutions (RAS) testing, and includes five scenarios where resistance testing is recommended. 
10 months 2 days ago
The Hepatitis C Trust, including the helpline, will close for Christmas at 4.30pm on Friday 21st December and will reopen on Monday 7th January 2019. The office will be unstaffed between these dates. We wish all of our contacts a Merry Christmas and look forward to continuing to provide support and information in the New Year.
10 months 6 days ago
The Infected Blood Inquiry team have announced meetings taking place across the UK between January and March, offering an opportunity for people to ask questions about the Inquiry and to get updates on the Inquiry team's work.  The team will be visiting the following locations between January and March next year: Nottingham - 29th January Birmingham - 30th January London - 7th February Newcastle - 12th February
10 months 3 weeks ago
Members of Scottish Parliament yesterday highlighted the importance of hepatitis C prevention and awareness as part of a broader debate on Scotland’s approach to drug and alcohol use.
10 months 4 weeks ago
Public Health England (PHE) and NHS England (NHSE) have today launched a national exercise, aimed at re-engaging patients previously diagnosed with hepatitis C but yet to access treatment.